Pipeline

INTERFERON ALPHA-2B (TOPICAL BIPHASIX CREAM)

AREA: HPV GENITAL (Female)
PRODUCT: AP-001
INDICATION: HPV Cervical High grade intraepithelial lesion (HSIL)
STATUS: Randomized, double-blind Phase 2b to start Q2 2020

DISCOVERY

PRE-CLINICAL

 

IND

 

PHASE 1

 

PHASE 2

 

PHASE 3

  • Current: Phase 2b
AREA: HPV GENITAL (Male)
PRODUCT: AP-001M
INDICATION: Genital HPV
STATUS: Discovery

DISCOVERY

PRE-CLINICAL

 

IND

 

PHASE 1

 

PHASE 2

 

PHASE 3

  • Current: Discovery

GALLIUM BASED SMALL MOLECULE NCE (ORAL)

AREA: Solid Tumors with Bone Metastases or at Risk of Bone Metastases
PRODUCT: AP-002
INDICATION: Solid tumors (with focus on breast, lung and prostate cancers)
STATUS: Phase 1-2 started Q4 2018 [NCT04143789]; Ongoing

DISCOVERY

PRE-CLINICAL

 

IND

 

PHASE 1

 

PHASE 2

 

PHASE 3

  • Current: Phase 1-2